p44/42 MAPKs are phosphorylated/activated by mitogens and are upregulated in human cancers, whereas p38 MAPK and JNK1/2 activation results either in apoptosis or in pro-survival depending on cell type and intensity of stress (Wagner and Nebreda, 2009). This evidence concerns the gene MAPK8 and cancer.